CASE CCC IN THE NEWS
Clinic's VeloSano Cycling Event Brings in More than $1.95 Million for Cancer Research
Crain's Business Cleveland - Nov 14, 2014
Cleveland Clinic announced its inaugural VeloSano cycling event raised more than $1.95 million to support cancer research at the health system..."We are extremely grateful to all who supported and participated in VeloSano's inaugural year," said Dr. Brian J. Bolwell, chairman of Clinic's Taussig Cancer Institute, in a release.
Multidisciplinary Teams in NSCLC Important for Optimal Patient Care
Targeted Oncology- Nov 13, 2014
Increasing knowledge of the diverse pathologic and molecular phenotypes in non-small cell lung cancer (NSCLC) has driven a more complex treatment algorithm in recent years. This complexity emphasizes the need for a multidisciplinary approach to better manage comprehensive, personalized patient care...Mutations in the epidermal growth factor receptor (EGFR) gene and translocations in the anaplastic lymphoma kinase (ALK)-tyrosine kinase receptor are 2 of the most common genetic abnormalities for which targeted treatments are available. Patrick C. Ma, MD, MS, from the Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, added that "a timely, multiplexed genomic profiling determination…is already becoming a new standard."
Coverage of Lung Cancer Screening Proposed by Medicare; Local Hospitals Praise the Move
The Plain Dealer - Nov 11, 2014
A proposal by the Centers for Medicare & Medicaid Services to cover the cost of lung cancer screening for a specific group of Medicare recipients is being welcomed by local hospitals that for years have been providing the service at a greatly reduced cost...The fact that Medicare is willing to cover the cost of a visit to talk specifically about lung cancer screening is significant, said Dr. Peter Mazzone, a Cleveland Clinic pulmonologist and member of the Case Comprehensive Cancer Center who has conducted extensive research on potential early lung cancer detection tools. "We all want to do that for every one of our patients, but traditionally there has been no support for that," he said. "To have 10 or 15 minutes in a [doctor's] office to talk about smoking cessation, blood pressure, exercise and to pay the appropriate amount of time to discuss the harms and benefits of screening is somewhat unrealistic."
Exploradio: Cleveland's growing stem cell scene
WKSU- Nov 10, 2014
The project is the brain-child of Stan Gerson, head of the National Center for Regenerative Medicine and Case Comprehensive Cancer Center. About the name of his center – he says, "it's not really regenerative exactly, it's cell therapy – it's restoration with cells rather than with drugs." He and his colleagues at Case were among the first to treat people using stem cells. But Gerson says that, despite the deep academic know-how here in Ohio, the East and West Coasts are where the stem-cell industry is taking root. "We don't have enough financial risk takers that are willing to take the same risks here that they might take on the coasts, and yet we know we're as competitive and as strong intellectually as anybody on the coasts are, so we need more investments," according to Gerson.
Case Western Reserve Center Wins Second Round of CDC Funding for Urban Public Health Research
The Plain Dealer - Nov 5, 2014
For the past five years, a large group of Cleveland's public health experts, headed up by the Prevention Research Center for Healthy Neighborhoods (PRCHN) at Case Western Reserve University, have been working together to tackle some of the biggest problems facing the city's urban neighborhoods...Last week, the center received a five-year $4.35 million grant from the Centers for Disease Control and Prevention to renew its operation, and another $2.97 million to fund ongoing projects focused on smoking cessation, living with epilepsy, and coping with chronic disease and dementia. "We've just brought in a ton of money, but it's not money that the university keeps – we're trying to build public health practice," said Elaine Borawski, the PRCHN's director and principal investigator and member of the Case Comprehensive Cancer Center. "We're not a traditional research center – our entire being is based on a community partnership, so it's a very different model for research."
NATIONAL DAY OF GIVING
CWRU #GivingTuesday to Benefit the Case Comprehensive Cancer Center
The Tuesday after Thanksgiving, Black Friday and Cyber Monday, is nationally recognized as "#GivingTuesday," a movement to create a day of giving to kick-off the giving season.
This year, #GivingTuesday falls on December 2. The Case Comprehensive Cancer Center has been selected by CWRU as one of several campus organizations to benefit from donations given on this day. If you are going to participate in #GivingTuesday, please consider donating locally and supporting the great work being done right here at home at the Cancer Center. We also hope you will encourage your friends and family join in this national movement.
AMERICAN ASSOCIATION FOR CANCER RESEARCH
AACR Annual Meeting 2015: Call for Clinical Trials Abstracts
The AACR Annual Meeting will be held April 18-22, 2015 in Philadelphia. AACR is encouraging attendees to submit clinical trials for presentation at the AACR Annual Meeting 2015 to facilitate the continued growth of the invaluable clinical content of this meeting. There will be at least 38 opportunities for the oral presentation of clinical trials at the Annual Meeting, including the presentation in the Opening Plenary Session of an outstanding clinical trial that holds promise for changing clinical practice and approaches. We also offer four marquee Clinical Trials Symposia which will feature tandem presentations of the trial data and the science informing the trial. Please keep in mind that there are also many poster sessions, including one focusing on highly informative "Trials in Progress."
Clinical trial abstracts that are available by the Wednesday, Dec. 3, 2014 deadline should be submitted to the appropriate Clinical Trial (CT) category. Late-breaking and placeholder abstracts should be submitted by Tuesday, Jan. 27, 2015. If a placeholder abstract is submitted, completed abstracts must be submitted no later than Friday, Feb. 27, 2015. Full instructions and guidelines for submitting clinical trials are available Annual Meeting website. Abstracts selected for presentation will be embargoed in accordance with AACR guidelines.
Call for Applications: Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
The Case Comprehensive Cancer Center invites applications to its funded program for research associates, for a start date of August 1, 2015. This program combines a mentored cancer research project designed by the fellow in collaboration with their mentors with a specialized curriculum of formal didactic training and individualized longitudinal curriculum.
This program is designed to prepare research associates for careers as: Independent investigators engaged in research at the intersection of cancer research, genetics, epidemiology, biostatistics, and computer science. Cancer researchers obtaining training will have the skills vital to decipher the complex pathways compromised of genetic and environmental risk factors for disease, and will ultimately be able to provide clinicians and their patients with valuable information for the prevention and treatment of cancer. Salary and research supply funds are highly competitive.
- US citizenship or permanent residency.
- Terminal degree (PhD, MD or MD/PhD).
- Demonstrated skills in quantitative analysis and an interest in a career in cancer genetics research.
Limited Submission: Damon Runyon Clinical Investigator Award
The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee. Visit the Cancer Center website for application information.
LOI Due to Cancer Center: November 17
Application Due to Sponsor: February 17, 2015
Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research
The Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research was established to recognize the outstanding achievement of a junior faculty-level scientist working in the field of cancer prevention, and support his or her novel and innovative research that, if successful, will have the potential for high impact in the cancer prevention field. The goal of the grant program is to encourage junior faculty, who have completed their most recent doctoral degree or medical residency within the past 11 years at the start of the grant term, to pursue novel, high-risk, high-reward cancer prevention research. Travel support is included to help foster interactions and collaborations among cancer scientists studying various aspects of cancer biology and to disseminate scientific knowledge about cancer prevention research within the field.
Deadline: December 9
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to Gillian Irwin at email@example.com.